Second Sight

Focus:

Type: Public Corporation
Founded: 1998


Second Sight manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence.

Leadership
Scott Dunbar
CEO


Financial Performance



Funding


Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2019
2.4M USD
Grant
2018
2M USD
Grant
Known Investors
Name
Type
HQ
Other Relevant Investments
Government Agency
United States
*More data available at: [CB Insights] [CrunchBase] [PitchBook]

Products and
Technologies
Argus II

Our Argus® II Retinal Prosthesis System is intended to provide useful vision to blind individuals severely impacted by RP. It combines a miniature eye implant with a patient-worn camera and processor to transform how you experience the world.

Implanting the Argus II is a well-established surgery, typically taking only a few hours. The procedure is performed by an experienced retinal surgeon, with Second Sight technicians available for your support. Once implanted, the Argus II implant sits in and around the back of the eye and is not visible to others. It is accompanied by external accessories that include glasses with a built in camera and a small portable processing unit that together capture and process video signals to be sent to the implant. Once the Argus II has been implanted, you will return to the clinic after approximately 4 weeks of healing to have your Argus II activated and programmed to your specific needs.

The Argus II was developed in-house through more than a decade of focused R&D efforts. As technology improves, so will your Argus II implant – without the need for additional surgery. Enjoy programming flexibility, and the capacity for future hardware and software upgrades.

Images

Videos


Related
News